Ardent Health Partners (ARDT)
Ardent Health Partners Statistics
Share Statistics
Ardent Health Partners has 142.75M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 142.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 87 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.38M, so 0.97% of the outstanding shares have been sold short.
Short Interest | 1.38M |
Short % of Shares Out | 0.97% |
Short % of Float | 6.05% |
Short Ratio (days to cover) | 5.06 |
Valuation Ratios
The PE ratio is 10.75 and the forward PE ratio is 7.58. Ardent Health Partners's PEG ratio is 0.03.
PE Ratio | 10.75 |
Forward PE | 7.58 |
PS Ratio | 0.38 |
Forward PS | 0.3 |
PB Ratio | 1.49 |
P/FCF Ratio | 17.74 |
PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ardent Health Partners.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 1.5.
Current Ratio | 1.94 |
Quick Ratio | 1.82 |
Debt / Equity | 1.5 |
Total Debt / Capitalization | 60 |
Cash Flow / Debt | 0.14 |
Interest Coverage | 5.54 |
Financial Efficiency
Return on equity (ROE) is 0.14% and return on capital (ROIC) is 7.88%.
Return on Equity (ROE) | 0.14% |
Return on Assets (ROA) | 0.04% |
Return on Capital (ROIC) | 7.88% |
Revenue Per Employee | $310,732.92 |
Profits Per Employee | $10,955.36 |
Employee Count | 19,200 |
Asset Turnover | 1.2 |
Inventory Turnover | 22.02 |
Taxes
Income Tax | 63.35M |
Effective Tax Rate | 0.17 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -1.17, so Ardent Health Partners's price volatility has been lower than the market average.
Beta | -1.17 |
52-Week Price Change | null% |
50-Day Moving Average | 14.4 |
200-Day Moving Average | null |
Relative Strength Index (RSI) | 39.12 |
Average Volume (20 Days) | 459.41K |
Income Statement
In the last 12 months, Ardent Health Partners had revenue of 5.97B and earned 210.34M in profits. Earnings per share was 1.59.
Revenue | 5.97B |
Gross Profit | 3.43B |
Operating Income | 363.06M |
Net Income | 210.34M |
EBITDA | 574.93M |
EBIT | 363.06M |
Earnings Per Share (EPS) | 1.59 |
Balance Sheet
The company has 556.78M in cash and 2.28B in debt, giving a net cash position of -1.73B.
Cash & Cash Equivalents | 556.78M |
Total Debt | 2.28B |
Net Cash | -1.73B |
Retained Earnings | 365.8M |
Total Assets | 4.96B |
Working Capital | 887.33M |
Cash Flow
In the last 12 months, operating cash flow was 315.03M and capital expenditures -187.51M, giving a free cash flow of 127.52M.
Operating Cash Flow | 315.03M |
Capital Expenditures | -187.51M |
Free Cash Flow | 127.52M |
FCF Per Share | 0.96 |
Margins
Gross margin is 57.51%, with operating and profit margins of 6.09% and 3.53%.
Gross Margin | 57.51% |
Operating Margin | 6.09% |
Pretax Margin | 6.09% |
Profit Margin | 3.53% |
EBITDA Margin | 9.64% |
EBIT Margin | 6.09% |
FCF Margin | 2.14% |
Dividends & Yields
ARDT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 12.06% |
FCF Yield | 6.78% |
Analyst Forecast
The average price target for ARDT is $21, which is 59.3% higher than the current price. The consensus rating is "Buy".
Price Target | $21 |
Price Target Difference | 59.3% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Scores
Altman Z-Score | 2.14 |
Piotroski F-Score | 8 |